Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DTBZ PET Imaging in Healthy Young and Elderly Subjects
NCT01838785Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jul 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of Florbenazine F-18 in Parkinson's disease (PD), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Age-Dependent Change in Striatal 18F-DTBZ Uptake at 2 years. Started Jul 2012; status: completed.
02
Drugs
Florbenazine F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01838785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838785.